Annual Total Liabilities
$95.08 M
-$9.23 M-8.85%
December 31, 2023
Summary
- As of February 7, 2025, LYEL annual total liabilities is $95.08 million, with the most recent change of -$9.23 million (-8.85%) on December 31, 2023.
- During the last 3 years, LYEL annual total liabilities has fallen by -$94.76 million (-49.92%).
- LYEL annual total liabilities is now -51.89% below its all-time high of $197.62 million, reached on December 31, 2021.
Performance
LYEL Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$88.52 M
+$877.00 K+1.00%
September 30, 2024
Summary
- As of February 7, 2025, LYEL quarterly total liabilities is $88.52 million, with the most recent change of +$877.00 thousand (+1.00%) on September 30, 2024.
- Over the past year, LYEL quarterly total liabilities has dropped by -$6.56 million (-6.90%).
- LYEL quarterly total liabilities is now -58.22% below its all-time high of $211.86 million, reached on September 30, 2021.
Performance
LYEL Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
LYEL Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.8% | -6.9% |
| 3 y3 years | -49.9% | -55.2% |
| 5 y5 years | -35.6% | -57.4% |
LYEL Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -51.9% | at low | -55.2% | +1.0% |
| 5 y | 5-year | -51.9% | at low | -58.2% | +1.0% |
| alltime | all time | -51.9% | at low | -58.2% | +1.0% |
Lyell Immunopharma Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $88.52 M(+1.0%) |
| Jun 2024 | - | $87.64 M(-3.8%) |
| Mar 2024 | - | $91.06 M(-4.2%) |
| Dec 2023 | $95.08 M(-8.9%) | $95.08 M(-2.4%) |
| Sep 2023 | - | $97.42 M(-1.1%) |
| Jun 2023 | - | $98.50 M(+1.9%) |
| Mar 2023 | - | $96.62 M(-7.4%) |
| Dec 2022 | $104.31 M | $104.31 M(-33.7%) |
| Sep 2022 | - | $157.24 M(+2.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $153.63 M(-19.5%) |
| Mar 2022 | - | $190.85 M(-3.4%) |
| Dec 2021 | $197.62 M(+4.1%) | $197.62 M(-6.7%) |
| Sep 2021 | - | $211.86 M(+1.9%) |
| Jun 2021 | - | $207.91 M(+3.8%) |
| Mar 2021 | - | $200.27 M(+5.5%) |
| Dec 2020 | $189.84 M(+28.6%) | - |
| Dec 2020 | - | $189.84 M |
| Dec 2019 | $147.58 M | - |
FAQ
- What is Lyell Immunopharma annual total liabilities?
- What is the all time high annual total liabilities for Lyell Immunopharma?
- What is Lyell Immunopharma annual total liabilities year-on-year change?
- What is Lyell Immunopharma quarterly total liabilities?
- What is the all time high quarterly total liabilities for Lyell Immunopharma?
- What is Lyell Immunopharma quarterly total liabilities year-on-year change?
What is Lyell Immunopharma annual total liabilities?
The current annual total liabilities of LYEL is $95.08 M
What is the all time high annual total liabilities for Lyell Immunopharma?
Lyell Immunopharma all-time high annual total liabilities is $197.62 M
What is Lyell Immunopharma annual total liabilities year-on-year change?
Over the past year, LYEL annual total liabilities has changed by -$9.23 M (-8.85%)
What is Lyell Immunopharma quarterly total liabilities?
The current quarterly total liabilities of LYEL is $88.52 M
What is the all time high quarterly total liabilities for Lyell Immunopharma?
Lyell Immunopharma all-time high quarterly total liabilities is $211.86 M
What is Lyell Immunopharma quarterly total liabilities year-on-year change?
Over the past year, LYEL quarterly total liabilities has changed by -$6.56 M (-6.90%)